Amgen was awarded the E. Donnall Thomas Medal of Achievement Medal
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Andras Nagy announced Canada’s first human embryonic stem cell lines
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
OMRF’s Sir Alexander Fleming scholar program celebrated it’s 50th class
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…
The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid. The…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
First cloned horse was born in North America
On Mar. 13, 2005, Paris Texas, the first cloned horse in North America was born at the College…
The FDA’s Drug Safety Oversight Board was formed
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
Autism Speaks was founded in New York City
On Feb. 11, 2005, Autism Speaks was founded in New York City by Bob and Suzanne Wright, grandparents…
The first meningococcal polysaccharide diphtheria toxoid conjugate vaccine (Menactra by Sanofi Pasteur) was licensed
On Jan. 14, 2005, the first meningococcal polysaccharide (Serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine…
The Institute for Translational Medicine and Therapeutics (ITMAT) was established
In Jan. 2005, the Institute for Translational Medicine and Therapeutics (ITMAT) was established at Penn’s Perelman School of…
Genome Alberta was established
In 2005, Genome Alberta, was established in partnership with Genome Canada Industry Canada and the Province of Alberta,…
The National Institute for Nanotechnology was founded
In 2005, the National Institute for Nanotechnology (NINT) was founded as a joint initiative between the Government of…
The California Institute for Regenerative Medicine was established
In 2005, the California Institute for Regenerative Medicine (CIRM) was formally established following the passage of Proposition 71…
The Penn Cardiovascular Institute (CVI) was established
In 2005, the Penn Cardiovascular Institute (CVI) was established as a collaborative multi-disciplinary group of basic and translational…
OHSU Clinical Outcomes Research Initiative received $2.5 million NIH grant
On Dec. 20, 2004, the Clinical Outcomes Research Initiative (CORI) based at OHSU anounnced it had received a…
TGen and IGC moved into their new state-of-the-art headquarters
In Dec. 2004, TGen and IGC moved into their new state-of-the-art headquarters. The six-story, $46 million building forms…
Biotechnology | Diagnostics | Genomics | Life Science News | Medicine | Non-Profit Research | Therapeutics
David H Murdock purchased the former Cannon Mills site at auction, future home of the North Carolina Research Campus
In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA)Â announced it had approved Genentech’s drug Tarceva…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU was awarded $4 million NIH biodefense contract to study tuberculosis
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
Linda Buck, from the Fred Hutchinson Cancer Research Center, was awarded the 2004 Nobel Prize for Medicine
On Oct. 4, 2004, the Nobel Assembly announced the award of the Nobel Prize in Physiology or Medicine…
The Hotchkiss Brain Institute was founded
In Oct. of 2004, the Hotchkiss Brain Institute was launched under the leadership of Dr. Samuel Weiss with…
UI Microbiology Professor Mark Stinski made the discoveries of CMV promoter and was named Iowa Inventor of the Year
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress
National Institutes of Health opened the Mark O Hatfield Clinical Research Center
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
OHSU announced collaboration with PNNL on biodefense project studying salmonella, pox viruses
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
The National Cancer Institute announced the Alliance for Nanotechnology in Cancer
On Sept. 13, 2004, the National Cancer Institute announced the Alliance for Nanotechnology in Cancer, a 5-year initiative…
Eli Lilly and Company launched new antidepressant Cymbalta
On Aug. 24, 2004, Eli Lilly and Company launched Cymbalta (duloxetine HC), a new treatment for major depression…
U.S. Congress passed The Minor Use and Minor Species Animal Health Act
On Aug. 2, 2004, the U.S. Congress passed the Minor Use and Minor Species Animal Health Act to…
Biotechnology | Chemical | Diagnostics | FDA | Infectious Disease | Life Science News | Radiology | Therapeutics | U.S. Congress
Project BioShield Act authorized FDA to expedite review procedures for treatments for chemical, biological and nuclear agents
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…